Clinical trial
Dual Therapy With Boosted Darunavir + Dolutegravir
NCT02486133
Study timeline
Study start (actual)2015-07-01Date precision: month
Registry last updated2023-11-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIV-Infectionunresolved
Interventions
PrezistaDRUG · verified · RxNorm: Prezista
NorvirDRUG · verified · RxNorm: Norvir
TivicayDRUG · verified · RxNorm: Tivicay
TruvadaDRUG · verified · RxNorm: Truvada
KivexaDRUG
DescovyDRUG · verified · RxNorm: Descovy
Sponsors & collaborators
Technical University of Munichlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02486133 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.